CHOP Clinical Trials
4 recruitingDrug
Phase 33Phase 21
Showing 1–4 of 4 trials
Recruiting
Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)132 enrolled1 locationNCT04002947
Recruiting
Phase 3
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Non-Hodgkin's LymphomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled17 locationsNCT06520163
Recruiting
Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Peripheral T Cell Lymphoma
Acrotech Biopharma Inc.504 enrolled69 locationsNCT06072131
Recruiting
Phase 3
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
Lymphoma
Sherief Abd-Elsalam60 enrolled1 locationNCT03647072